KIZ OpenIR  > 科研部门  > 生物毒素与人类疾病(张云)
PAR4 和TFF2 在胃肠癌中的表达变异与临床关系以及 TFF2 的重组表达
其他题名The investigation of PAR4 and TFF2 in gastrointestinal cancers and the prokaryotic expression of recombinant TFF2
余果宇
学位类型博士
导师张云
2010
学位授予单位中国科学院研究生院
学位授予地点北京
摘要胃癌和肠癌是常见的威胁人类健康的消化道恶性肿瘤,其发生发展涉及多因 子的作用及调控。其中,在胃肠道都有表达的蛋白酶激活受体(PARs)和三叶 因子蛋白(TFFs)家族都参与肿瘤发生发展的调控过程。正常生理条件下,PARs 的表达与胃肠道消化液的分泌和肌肉的收缩舒张相关。同时,在胃肠道肿瘤的发 生、浸润和转移过程中PARs和TFF2也发挥了作用。而PAR-4,除了具有凝血酶 激活后的血小板聚集功能外,还参与感染、细胞迁移和肿瘤的发生发展。在溃疡 性结肠炎,肠癌组织以及某些肠癌细胞系中都出现PAR4的异常表达,而这种异 常表达可能作为启动肠癌发生的重要环节。TFFs家族蛋白能够对抗粘膜损伤并 且参与修复以发挥保护胃肠道的功能。在肿瘤发生中,三叶因子既有报道作为肿 瘤抑制因子,又有报道作为潜在的肿瘤促进因子。含两个三叶因子结构域的 TFF2,主要表达在胃粘膜的颈细胞。在胃溃疡、慢性萎缩性胃炎及胃癌中,TFF2 的表达具有下降的趋势;而且分化程度越低的胃癌,TFF2的表达量越少,这是 因为TFF2的表达与胃粘膜细胞的增殖和恶性转移相关。在肠道,TFF2可以抑制 一氧化氮(NO)的生成以调节由NO引起的肠炎;在肠炎老鼠的模型中,TFF2 能减轻炎症和溃疡发生的程度,表明TFF2可能通过调节机体的免疫反应来抑制 肠道炎症的发生。 而本实验室前期对大蹼铃蟾皮肤分泌物中获得的新型血小板激动蛋白 -Bm-TFF2与PARs相互作用的实验,促使我们去研究人TFF2与PARs的关系。由 于免疫组化提示TFF2和PAR4在正常胃黏膜中都分布在从基底部到中间的位置, 而且TFF2第二个Loop区序列的保守性,以及和PAR4连接配体(tethered-ligand) 的高度相似性,促使我们推测PAR4和TFF2之间是否存在一种相互作用,或者 hTFF2是否能调节PAR4的生物学活性。所以该篇论文落脚于PAR4和hTFF2,着 重介绍PAR4和TFF2在胃肠道肿瘤中的表达变异以及TFF2对过表达PAR4的细胞 的趋化作用。 我们先用半定量PCR方法检测TFF2和PAR4在胃癌、肠癌及周围远癌部位组 织中mRNA的表达水平。结果提示两个基因在胃癌组织中的表达较周围远癌部位组织减弱,而在肠癌组织中的表达则较周围远癌部位组织增强。Western blotting 也得到相似的结果。为进一步明确PAR4和TFF2在胃癌和肠癌中表达的具体变化 情况,我们继而用实时荧光定量PCR对28例胃癌和38例肠癌及其周围远癌部位组 织中TFF2和PAR4的表达进行了研究。结果显示胃癌组织中两个基因mRNA的表 达都显著低于远癌部位组织(P<0.001),而肠癌组织中两个基因mRNA的表达 则显著高于远癌部位组织(P<0.001)。结合临床病理资料提示PAR4在淋巴结转 移的胃癌患者中的表达低于无淋巴结转移的患者(P<0.05),在胃窦癌中的表达 明显低于非胃窦癌(P<0.05);而发生淋巴结转移的肠癌患者其TFF2和PAR4基 因的表达都显著高于无淋巴结转移的肠癌患者(P<0.05);两个基因在中低分化 肠癌中的表达也显著高于高分化肠癌(P<0.001)。免疫组化结果也提示TFF2和 PAR4在胃癌中的表达显著低于周围远癌部位组织(P<0.001),而在肠癌中的表 达则显著高于周围远癌部位组织(P<0.001)。表明TFF2和PAR4在胃肠道肿瘤的 发生中可能受到某些因素的调节而协调性地一致性表达。 在细胞水平上,我们发现在同等浓度hTFF2的诱导下,过表达PAR4的Lovo 稳定株的细胞迁移能力较不表达者明显增强,并且hTFF2的促细胞迁移活性呈剂 量依赖性,同时伴随ERK1/2磷酸化的增强。同时,过表达PAR4的Lovo细胞增殖 能力强于无PAR4表达的细胞,但TFF2作用后其增强能力反而下降,表明TFF2 对过表达了PAR4的Lovo细胞具有抗增殖的能力。 总之这些结果提示PAR4和TFF2在胃肠道中协同表达的现实为两者之间产 生一定的作用提供了基础,而且这种共存为粘膜受损后的修复,组织自身平衡状 态的维持都发挥了一定的作用,同时也为临床相关疾病的诊断,治疗及预后提供 一个新的理论依据。当然,生理和病理情况下,存在于PAR4和TFF2之间的调控 和相互作用的分子机制仍不清楚,这也是进一步研究的关键所在。 为探讨其它动物体内三叶因子家族蛋白结构和功能的关系,我们进而利用原 核表达体系构建并表达纯化了Bm-TFF2以及它的两个单结构域。由于Bm-TFF2 分子中有三对二硫键,所以我们选用pET-32a表达体系表达融合的重组蛋白,并 利用融合蛋白N端引入的Xa因子酶切位点将融合蛋白中的硫氧还蛋白切除,亲和 柱及反向高压液相色谱纯化游离的重组蛋白。重组的Bm-TFF2全长具有血小板聚集活性,而第一个结构域只有诱导血小板变形的作用;三种重组蛋白都具有剂量 依赖性地诱导AGS细胞迁移的功能,但三种重组蛋白的细胞迁移活性无明显差 异。pET-32a表达体系成功表达Bm-TFF2的事实为我们研究人三叶因子家族蛋白 结构及功能关系提供一种方便而可靠的手段。
其他摘要Gastric cancer and colorectal cancer are common gastrointestinal tumors threatening human health, which are related to many factors during its development. The protease activated receptors (PARs) and trefoil factor protein (TFFs) family expressed in the gastrointestinal tract are involved in the development. In physiological conditions, PARs is related to the secretion of digestive juice and the contraction and relaxation of muscle. Meanwhile, PARs also plays a role in cancer development, invasion and metastasis besides platelet aggregation. Aberrant expression of PAR4 had been detected in ulcerative colitis, colorectal cancer and certain cancer cell lines, which might be important in initiating colorectal cancer.formation. TFFs is in involved in protecting gastrointestinal tract against mucosal damage and play an important role in the subsequent repair. During the development of cancer, TFFs was reported as a tumor suppressor factor in some cases, but as a potential tumor promoting factor in others. TFF2, consisting of two trefoil factor domains, is mainly expressed in the neck cells of gastric glands. The level of TFF2 was in line with the degree of cell differentiation and and decreased in gastric ulcer, chronic atrophic gastritis and gastric cancer. As reported, the expression of TFF2 is related to gastric mucosal cell proliferation and malignant transformation. In intestine, TFF2 inhibited the development of colitis induced by the NO. In mice colitis model, TFF2 reduced the degree of inflammation and ulcers which suggested TFF2 is involved in the immune response. Based on our previous studied on the interaction between PARs and Bo-TFF2, which could induced human platelet aggregation, we were prompted to study the relationship between hTFF2 and PARs. Immunohistochemistry staining showed that both hTFF2 and PAR4 are distributed in the normal gastric mucosa from base to the middle position. Partial sequences of the second Loop of hTFF2, are conservative and shwows high similarity with tethered-ligand of PAR4. In the study, we invesgated whether there exists an interaction between TFF2 and PAR4, and the biological activity of PAR4 is regulated by TFF2 or not. The variant expression of TFF2 and PAR4 in gastrointestinal cancer and the chemotaxis of TFF2 to cells overexpression PAR4 were discussed. At first, We tested the expression of TFF2 and PAR4 in gastric and colorectal cancer by semi-quantitative PCR. The results suggested that both gene’s expression were two gene expression was significantly lower in gastric cancer tissue than in the normal tissue but higher in colorectal cancer tissue. Similar results were shown by Western blotting. To further define the variant quantity of TFF2 and PAR4 in gastric cancer and colorectal cancer, two genes’ expression in 28 gastric cancers and 38 colorectal cancers were were quantifiedf. The results showed that mRNA level of both genes in cancer tissue were significantly lower than in normal gastric tissue (P<0.001), but significantly higher in colorectal cancer (P<0.001). Clinical pathology results suggested that the level of PAR4 in gastric cancer patients with lymph node metastasis was lower than without lymph node metastasis.The level of PAR4 gene expression was lower in gastric antrum than in no-gastric antrum cancer (P <0.05). However, the level of TFF2 and PAR4 in colorectal cancer patients with lymph node metastasis was higher than no lymph node metastasis, and was also significantly higher in poorly differentiated colorectal carcinoma than in well-differentiated cancer (P<0.001). By immunohistochemical analysis, the protein level of TFF2 and PAR4 in gastric adenocarcinoma was significantly lower than in the surrounding normal mucosa (P<0.001), but higher in colorectal carcinoma accordingly (P<0.001). And the results showed that both TFF2 and PAR4 were expressed consistently in the gastrointestinal tract cancer. The migration of lovo-PAR4 was evidently increased comparing with lovo-mock cell after induced by same concentration of hTFF2, the activity performed in a dose-dependent manner accompanied by increasing phosphorylation of ERK1/2. The proliferation activity of PAR4 comparing with the mock cell, but the activity decreased after induced by TFF2, which demonstrated the anti-proliferative capacity domain truncation. Since having three disulfide bonds, we expressed recombinant fusion proteins by pET32a expression system, removed thioredoxin by Xa factor, and purified free recombinant proteins by affinity chromatography and reverse high pressure liquid chromatography column. The recombinant Bm-TFF2 had platelet aggregation activity, and the first domain of Bm-TFF2 only induced platelet deformities. However, three recombinant proteins have the function of inducing AGS migration, and the migration activity was in a dose-dependent, and there is no evident activity difference among three recombinant proteins. The facts provided a convenient and reliable means for studying the relationships of structure and function of TFFs protein family.
语种中文
文献类型学位论文
条目标识符http://ir.kiz.ac.cn/handle/152453/6494
专题科研部门_生物毒素与人类疾病(张云)
推荐引用方式
GB/T 7714
余果宇. PAR4 和TFF2 在胃肠癌中的表达变异与临床关系以及 TFF2 的重组表达[D]. 北京. 中国科学院研究生院,2010.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
2010007.pdf(6662KB) 开放获取使用许可请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[余果宇]的文章
百度学术
百度学术中相似的文章
[余果宇]的文章
必应学术
必应学术中相似的文章
[余果宇]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。